The effect of the vaccine for COVID-19 on menstrual cycle symptoms in healthy wome

Not Applicable

• Conditions: Menstrual symptoms; COVID 19 vaccine; Reproductive Health and Childbirth - Menstruation and menopause; Inflammatory and Immune System - Normal development and function of the immune system

• Registration Number: ACTRN12621001317886
• Lead Sponsor: Endometriosis research group, The Royal Women's hospital VIC

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-09-28
• Last Update Posted: 4 October 2021

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Female
• Target Recruitment: 1200

Inclusion Criteria

•Premenopausal individuals who have had at least one period in the past
•Currently having periods or
•Currently not having periods due to other reasons eg. using hormonal contraceptives, using gender affirming hormones
•Have not yet been vaccinated but are planning on having the COVID-19 vaccine soon or have received their first dose on day of recruitment
•Healthy people (without blood disorders or known hematological diseases)
•Aged 18-45
•Interested in participating in the study and consent to regular monitoring of their menstruation.

Exclusion Criteria

•People who are already vaccinated against COVID
•People who never had periods
•People who are post menopausal, pregnant, breastfeeding or who plan pregnancy in the next 12 months.
•People who have had a hysterectomy

Study & Design

• Study Type: Observational
• Study Design: Not specified